Rapid accelerated hemodialysis in children with end-stage renal disease: a randomized clinical trial

Mohamed Khaled El Hatw1, Fatina Fadel, Ramzy El Baroudy

  • 1Cairo University Children's Hospital, Cairo, Egypt. melhatw@yahoo.com

Insights

Rapid accelerated hemodialysis with recirculation (R-AHD PR) allows for reduced heparin use in pediatric patients undergoing dialysis. However, this method did not improve overall dialysis efficiency compared to standard treatments.

Area of Science:

  • Nephrology
  • Pediatric Dialysis
  • Cardiovascular Engineering

Background:

  • Rapid Accelerated Hemodialysis (R-AHD) is a technique designed to increase blood flow rate (BFR) through partial recirculation.
  • R-AHD PR utilizes two blood pump segments to manage recirculation, aiming to enhance anticoagulation and dialysis efficiency.
  • Pediatric end-stage renal disease patients require effective and safe dialysis strategies, particularly concerning anticoagulation.

Purpose of the Study:

  • To evaluate the effectiveness of R-AHD PR in improving anticoagulation and dialysis efficiency in children with end-stage renal disease.
  • To assess the feasibility of using reduced or no heparin with R-AHD PR.
  • To compare R-AHD PR outcomes with conventional double needle hemodialysis (DNHD).

Main Methods:

  • A two-stage study involving ten pediatric patients with end-stage renal disease.
  • Stage 1: Assessed various R-AHD protocols with different heparin doses, followed by a control period of DNHD.
  • Stage 2: Compared R-AHD PR with DNHD, including protocols with low-dose and no heparin, monitoring blood clotting and urea reduction rates.

Main Results:

  • Blood clots occurred in 4 out of 165 R-AHD sessions but in none of the 28 R-AHD PR sessions.
  • Mean urea reduction rates in Stage 1 were comparable between R-AHD protocols (0.60-0.70) and control DNHD (0.71).
  • In Stage 2, R-AHD PR showed a trend towards lower urea reduction (0.66 ± 0.15) compared to DNHD (0.79 ± 0.18), though not statistically significant (P=0.059).

Conclusions:

  • R-AHD PR enables successful hemodialysis in children using low or no heparin without increasing patient blood flow rate.
  • The R-AHD PR technique did not demonstrate an improvement in dialysis efficiency compared to standard DNHD.
  • R-AHD PR shows promise for reduced anticoagulation in pediatric hemodialysis, warranting further investigation into its efficiency.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...